PE73099A1 - Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento de los edemas cerebrales - Google Patents
Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento de los edemas cerebralesInfo
- Publication number
- PE73099A1 PE73099A1 PE1998000385A PE00038598A PE73099A1 PE 73099 A1 PE73099 A1 PE 73099A1 PE 1998000385 A PE1998000385 A PE 1998000385A PE 00038598 A PE00038598 A PE 00038598A PE 73099 A1 PE73099 A1 PE 73099A1
- Authority
- PE
- Peru
- Prior art keywords
- molecular weight
- low molecular
- heparines
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
CARACTERIZADA PORQUE LA HEPARINA TIENE UN PESO MOLECULAR MEDIO COMPRENDIDO ENTRE 1000 Y 10000 DALTONS, EN PARTICULAR ENTRE 4000 Y 5000 DALTONS; PREFERENTEMENTE LAS HEPARINAS ESTAN CONSTITUIDAS POR OLIGOSACARIDOS QUE TIENEN UN ACIDO 2-O-SULFO-4-ENOPIRANOSURONICO EN UNA DE SUS EXTREMIDADES. TAMBIEN SE REFIERE A LA OBTENCION PARTICULARMENTE VENTAJOSA POR DESPOLIMERIZADO DE UN ESTER DE LA HEPARINA POR MEDIO DE UNA BASE TAL COMO SOSA. LAS HEPARINAS PUEDEN SER ENOXAPARINA, NADROPARINA, PARNAPARINA, REVIPARINA, ENTRE OTRAS; QUE PUEDEN SER UTILES PARA LA PREVENCION Y EL TRATAMIENTO DE LOS EDEMAS CEREBRALES
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9706551A FR2763849B1 (fr) | 1997-05-28 | 1997-05-28 | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux |
Publications (1)
Publication Number | Publication Date |
---|---|
PE73099A1 true PE73099A1 (es) | 1999-10-21 |
Family
ID=9507336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1998000385A PE73099A1 (es) | 1997-05-28 | 1998-05-19 | Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento de los edemas cerebrales |
Country Status (24)
Country | Link |
---|---|
US (1) | US6579858B1 (es) |
EP (1) | EP0984787B1 (es) |
JP (1) | JP2002502387A (es) |
KR (1) | KR100562425B1 (es) |
CN (1) | CN1223351C (es) |
AT (1) | ATE225181T1 (es) |
AU (1) | AU742995B2 (es) |
BR (1) | BR9809180A (es) |
CA (1) | CA2290682A1 (es) |
DE (1) | DE69808455T2 (es) |
DK (1) | DK0984787T3 (es) |
ES (1) | ES2182321T3 (es) |
FR (1) | FR2763849B1 (es) |
IL (2) | IL132670A0 (es) |
MA (1) | MA24554A1 (es) |
NO (1) | NO317003B1 (es) |
NZ (1) | NZ501366A (es) |
PE (1) | PE73099A1 (es) |
PT (1) | PT984787E (es) |
RU (1) | RU2195287C2 (es) |
TN (1) | TNSN98072A1 (es) |
TW (1) | TW546141B (es) |
WO (1) | WO1998053834A1 (es) |
ZA (1) | ZA984433B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2787329B1 (fr) * | 1998-12-17 | 2001-02-09 | Aventis Pharma Sa | Nouvelle application therapeutique des heparines de bas poids moleculaire |
JP2005505537A (ja) * | 2001-08-28 | 2005-02-24 | レオ・ファーマ・アクティーゼルスカブ | 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物 |
ITMI20031023A1 (it) * | 2003-05-21 | 2004-11-22 | Umberto Cornelli | Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali. |
US11840565B2 (en) | 2016-12-29 | 2023-12-12 | University Of Miami | Methods and compositions for treating virus-associated inflammation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2013092C1 (ru) * | 1989-02-27 | 1994-05-30 | Дагестанский государственный медицинский институт | Способ лечения отека мозга при туберкулезном менингоэнцефалите |
-
1997
- 1997-05-28 FR FR9706551A patent/FR2763849B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-19 PE PE1998000385A patent/PE73099A1/es not_active Application Discontinuation
- 1998-05-25 DK DK98925774T patent/DK0984787T3/da active
- 1998-05-25 CN CNB988054906A patent/CN1223351C/zh not_active Expired - Fee Related
- 1998-05-25 EP EP98925774A patent/EP0984787B1/fr not_active Expired - Lifetime
- 1998-05-25 JP JP50031199A patent/JP2002502387A/ja not_active Ceased
- 1998-05-25 TW TW087108064A patent/TW546141B/zh not_active IP Right Cessation
- 1998-05-25 AU AU77760/98A patent/AU742995B2/en not_active Ceased
- 1998-05-25 DE DE69808455T patent/DE69808455T2/de not_active Expired - Lifetime
- 1998-05-25 ES ES98925774T patent/ES2182321T3/es not_active Expired - Lifetime
- 1998-05-25 PT PT98925774T patent/PT984787E/pt unknown
- 1998-05-25 IL IL13267098A patent/IL132670A0/xx unknown
- 1998-05-25 BR BR9809180-8A patent/BR9809180A/pt not_active Application Discontinuation
- 1998-05-25 KR KR1019997011052A patent/KR100562425B1/ko not_active IP Right Cessation
- 1998-05-25 AT AT98925774T patent/ATE225181T1/de not_active IP Right Cessation
- 1998-05-25 MA MA25089A patent/MA24554A1/fr unknown
- 1998-05-25 RU RU99128103/14A patent/RU2195287C2/ru not_active IP Right Cessation
- 1998-05-25 WO PCT/FR1998/001035 patent/WO1998053834A1/fr active IP Right Grant
- 1998-05-25 CA CA002290682A patent/CA2290682A1/fr not_active Abandoned
- 1998-05-25 NZ NZ501366A patent/NZ501366A/xx unknown
- 1998-05-25 ZA ZA984433A patent/ZA984433B/xx unknown
- 1998-05-27 TN TNTNSN98072A patent/TNSN98072A1/fr unknown
-
1999
- 1999-11-01 IL IL132670A patent/IL132670A/en not_active IP Right Cessation
- 1999-11-12 NO NO19995539A patent/NO317003B1/no not_active IP Right Cessation
- 1999-11-29 US US09/450,110 patent/US6579858B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NZ501366A (en) | 2000-11-24 |
EP0984787B1 (fr) | 2002-10-02 |
JP2002502387A (ja) | 2002-01-22 |
DE69808455T2 (de) | 2003-07-03 |
TNSN98072A1 (fr) | 2005-03-15 |
PT984787E (pt) | 2003-01-31 |
BR9809180A (pt) | 2000-08-01 |
TW546141B (en) | 2003-08-11 |
IL132670A (en) | 2010-05-31 |
EP0984787A1 (fr) | 2000-03-15 |
FR2763849B1 (fr) | 2000-09-15 |
IL132670A0 (en) | 2001-03-19 |
CN1257429A (zh) | 2000-06-21 |
AU7776098A (en) | 1998-12-30 |
KR100562425B1 (ko) | 2006-03-17 |
AU742995B2 (en) | 2002-01-17 |
ATE225181T1 (de) | 2002-10-15 |
WO1998053834A1 (fr) | 1998-12-03 |
RU2195287C2 (ru) | 2002-12-27 |
DE69808455D1 (de) | 2002-11-07 |
DK0984787T3 (da) | 2003-02-03 |
NO995539L (no) | 1999-11-12 |
ZA984433B (en) | 1998-12-28 |
US6579858B1 (en) | 2003-06-17 |
MA24554A1 (fr) | 1998-12-31 |
CA2290682A1 (fr) | 1998-12-03 |
ES2182321T3 (es) | 2003-03-01 |
NO317003B1 (no) | 2004-07-19 |
NO995539D0 (no) | 1999-11-12 |
FR2763849A1 (fr) | 1998-12-04 |
KR20010013073A (ko) | 2001-02-26 |
CN1223351C (zh) | 2005-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
UA27911C2 (uk) | Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну | |
PT979096E (pt) | Tratamento de enfartes atraves da inibicao de nf-kb | |
DE69622752T2 (de) | Verbandssystem | |
MX9204820A (es) | Bota de compresion para el tratamiento de un miembro lastimado. | |
ES2082887T3 (es) | Flupirtina en combinacion con antiparkinsonianos para combatir espasmos musculares. | |
ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
ES2123499T3 (es) | Metodos y composiciones para tratamiento de infecciones virales. | |
PE73099A1 (es) | Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento de los edemas cerebrales | |
SE9601395D0 (sv) | New therapeutic treatment 1 | |
ES2181702T3 (es) | Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño. | |
SE9601396D0 (sv) | New therapeutic treatment 2 | |
ECSP003590A (es) | Compuestos calcioliticos | |
ES1022449Y (es) | Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades. | |
PT869785E (pt) | 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente | |
MX9203362A (es) | Composicion diuretica de benazepril/tiazida de dosis baja, para el tratamiento de la hipertension | |
AR015537A1 (es) | Uso de brinzolamida para la manufactura de un medicamento para tratar o prevenir edema de retina. | |
ES2190499T3 (es) | Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer. | |
DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine | |
ATE74505T1 (de) | Schmerzpraeparat. | |
ES2167942T3 (es) | Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes. | |
ES2054097T3 (es) | Agente para el tratamiento de enfermedades inflamatorias cronicas del intestino. | |
PT967986E (pt) | Utilizacao de glicoproteina alfa1-acida para a preparacao de um preparado farmaceutico | |
EA200200750A1 (ru) | Новое терапевтическое применение еноксапарина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |